Employers Survey Could Boost Drug-Pricing Reform Prospects

By Amy Lotven / May 17, 2021 at 1:20 PM
Key health policy experts from both sides of the political spectrum say a recent survey by the Purchasers Business Group on Health (PBGH) and the Kaiser Family Foundation (KFF) finding employers are increasingly open to government intervention to rein in health care costs could boost the prospects of Congress acting this year to lower prescription drug costs. Lanhee Chen, a fellow at the Hoover Institute, Chris Jennings of Jennings Policy Strategy, Elizabeth Mitchell of the PBGH and KFF officials participated...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.